The global leader in USAN/INN naming, partnering on 76% of USAN and 78% of INN drug name approvals!

550
Healthcare Clients
4055
Total Healthcare Names
713
Oncology Names
CLIENTNAMECATEGORY
INSPIRAabequolixronOncology
INSPIRAabequolixron zincOncology
PHARMACYCLICSabexinostatOncology
ASTRAZENECAacalabrutinibOncology
ACERTA PHARMAacalabrutinibOncology
GILEADacalisibOncology
AMGENacapatamabOncology
MODERNAacavameranOncology
ACTINIUMactinium (225ac) lintuzumab satetraxetanOncology
MIRATIadagrasibOncology
ASTRAZENECAadavosertibOncology
ADAPTIMMUNEafamitresgene autoleucelOncology
ADAPTIMMUNEafamitresgene autoleucelOncology
PFIZERagatolimodOncology
SHIONOGI PHARMAalicdamotideOncology
TAKEDAalisertibOncology
GILEADalobresibOncology
KYMABalomfilimabOncology
ASCENTAGE PHARMAalrizomadlinOncology
FIVE PRIME THERAPEUTICSalsevalimabOncology
CHONG KUN DANGalteminostatOncology
BRISTOL MYERS SQUIBBalvespimycinOncology
BRISTOL MYERS SQUIBBalvespimycin hydrochlorideOncology
SANOFIamcenestrantOncology
SANOFIamcenestrantOncology
JANSSENamivantamabOncology
KYMABamlitelimabOncology
BRISTOL MYERS SQUIBBamrubicin hydrochlorideOncology
BRII BIOSCIENCESamubarvimabOncology
GILEADandecaliximabOncology
JANSSENapalutamideOncology
BAYERaprutumabOncology
BAYERaprutumab ixadotinOncology
ISOFOLarfolitixorinOncology
BIOSIGHTaspacytarabineOncology
GSKastuprotimut-rOncology
SHIONOGI PHARMAasudemotideOncology
GENENTECHatezolizumabOncology
EQRXaumolertinibOncology
EQRXaumolertinib mesylateOncology
GENENTECHautogene cevumeranOncology
GENENTECHautogene cevumeranOncology
BASILEA PHARMACEUTICAavanbulinOncology
BLUEPRINT MEDICINESavapritinibOncology
NEKTARavipendekin pegolOncology
BEYONDBIOavotaciclibOncology
ADVAXISaxalimogene filolisbacOncology
SYNDAXaxatilimabOncology
ABBVIEazintuxizumabOncology
ABBVIEazintuxizumab vedotinOncology
MERCK & CO.baloramotideOncology
ISU ABXISbarecetamabOncology
ARIVIVEbatiraxceptOncology
ARVINASbavdegalutamideOncology
GSKbelantamabOncology
GSKbelantamab mafodotinOncology
SPECTRUM PHARMACEUTICALSbelinostatOncology
GSKbelizatinibOncology
HANMI PHARMACEUTICALSbelvarafenibOncology
MERCK & CO.belzutifanOncology
FIVE PRIME THERAPEUTICSbemarituzumabOncology
BERGEN BIObemcentinibOncology
ATEA PHARMACEUTICALSbemnifosbuvirOncology
ATEA PHARMACEUTICALSbemnifosbuvir sulfateOncology
NEKTARbempegaldesleukinOncology
BioInvent InternationalbersanlimabOncology
VERTEX PHARMACEUTICALSberzosertibOncology
AMGENbevacizumab betaOncology
ASTRAZENECAbicalutamideOncology
PIQURbimiralisibOncology
Inoviobizalimogene ralaplasmidOncology
MEDIMMUNEblinatumomabOncology
AGENUSbotensilimabOncology
MEREO BIOPHARMbrontictuzumabOncology
ABBVIEbudigalimabOncology
FIVE PRIME THERAPEUTICScabiralizumabOncology
EXELIXIScabozantinibOncology
MERCK & CO.cadalimogene ixalentivecOncology
ADC THERAPEUTICScamidanlumabOncology
ADC THERAPEUTICScamidanlumab tesirineOncology
ASTRAZENECAcamizestrantOncology
MONOPARcamsirubicinOncology
TAKARA BIOcanerpaturevOncology
IMMUNOGENcantuzumab ravtansineOncology
ASTRAZENECAcapivasertibOncology
ADVAXIScapolimogene apralisbacOncology
JOHNSON & JOHNSONcarlumabOncology
TRACON PHARMACEUTICALScarotuximabOncology
AstexcedazuridineOncology
ABBVIEcedirogantOncology
ASTRAZENECAceralasertibOncology
ALEXION PHARMACEUTICALScerdulatinibOncology
JanssencetrelimabOncology
GENENTECHcevostamabOncology
JANSSENciltacabtagene autoleucelOncology
PIERIS PHARMACEUTICALScinrebafusp alfaOncology
LYCERAcintirorgonOncology
SAMUMEDcirtuvivintOncology
GENENTECHcobimetinibOncology
BAYERcopanlisibOncology
GENORBIOcoprelotamabOncology
CHECKPOINT THERAPEUTICScosibelimabOncology
GILEADdalutrafusp alfaOncology
CHINOOK THERAPEUTICSdamistimagene matitucelOncology
ASTRAZENECAdanvatirsenOncology
JANSSENdaratumumabOncology
BAYERdarolutamideOncology
IDEAYA BIOSCIENCESdarovasertibOncology
DAIICHI-SANKYOdatopotamabOncology
DAIICHI-SANKYOdatopotamab deruxtecanOncology
CERULEANdavamotecan pegadexamerOncology
REGENERONdavutamigOncology
ASTRAZENECAdefosbarasertibOncology
MEREO BIOPHARMdemcizumabOncology
NANOCARRIERdemplatin pegraglumerOncology
SEAGENdenintuzumab mafodotinOncology
ABBVIEdepatuxizumabOncology
ABBVIEdepatuxizumab mafodotinOncology
ARQULEderazantinibOncology
ARQULEderazantinib hydrochlorideOncology
RAFAEL PHARMACEUTICALSdevimistatOncology
APOTEXdocetaxelOncology
CANTEX PHARMACEUTICALSdociparstatOncology
ARCUSdomvanalimabOncology
NOVARTISdovitinibOncology
NOVARTISdovitinib lactateOncology
GENENTECHdulanerminOncology
GENENTECHduligotuzumabOncology
JANSSENduvortuxizumabOncology
KURAedaxeterkibOncology
MEREO BIOPHARMefaprinermin alfaOncology
MEDIMMUNEefgivanermin alfaOncology
Genexineefineptakin alfaOncology
ABBVIEeftozanermin alfaOncology
RADIUS HEALTHelacestrantOncology
SYNTA PHARMACEUTICALSelesclomolOncology
ABBVIEelotuzumabOncology
ONCOTHERAPY SCIENCEelpamotideOncology
ACTUATE THERAPEUTICSelraglusibOncology
PFIZERelranatamabOncology
PFIZERelranatamabOncology
AMGENeluvixtamabOncology
CURISemavusertibOncology
CURISemavusertib hydrochlorideOncology
AMGENemerfetamabOncology
AGIOSenasidenibOncology
ABBOTT LABORATORIESenavatuzumabOncology
GSKencelimabOncology
ATHENEXencequidarOncology
SEAGENenfortumab vedotinOncology
CHINOOK THERAPEUTICSenistimagene setitucelOncology
XCOVERYensartinibOncology
NEOGENIX ONCOLOGYensituximabOncology
GILEADentospletinibOncology
IGNYTAentrectinibOncology
PFIZERenzalutamideOncology
SHIONOGI PHARMAepertinibOncology
APREAeprenetapoptOncology
SPECTRUM PHARMACEUTICALSeramkafusp alfaOncology
MEDIMMUNEetaracizumabOncology
AMGENetevritamabOncology
OnxeoetidaligideOncology
MEREO BIOPHARMetigilimabOncology
NEKTARetirinotecan pegolOncology
NEKTARetirinotecan pegol tetrahydrochlorideOncology
NEKTARetirinotecan pegol tetratriflutateOncology
ARCUSetrumadenantOncology
SYNDEVRXevexomostatOncology
GILEADevixapodlinOncology
EMD SERONOevobrutinibOncology
CRISPRevoncabtagene pazurgedleucelOncology
SANOFIfedratinibOncology
GSKfeladilimabOncology
STEMLINE THERAPEUTICSfelezonexorOncology
MORPHOSYSfelzartamabOncology
NIPPON KAYAKUfirtecan peglumerOncology
BLUEPRINT MEDICINESfisogatinibOncology
SIEMENSflortanidazole (18f)Oncology
SIEMENSflotegatide (18f)Oncology
BLUE EARTH DIAGNOSTICSflotufolastat (18f)Oncology
MAST THERAPEUTICSfolitixorinOncology
MAST THERAPEUTICSfolitixorin calciumOncology
OXIGENEfosbretabulinOncology
OXIGENEfosbretabulin disodiumOncology
OXIGENEfosbretabulin tromethamineOncology
BIONOVUS LIFE SCIENCESfosciclopiroxOncology
NUCANAfosgemcitabine palabenamideOncology
NUCANAfosifloxuridine nafalbenamideOncology
TAIRXfoslinanibOncology
MEDIVIRfostroxacitabine bralpamideOncology
BEIGENEgarivulimabOncology
GLYCOTOPEgatipotuzumabOncology
SANOFI GENZYMEgatralimabOncology
PFIZERgemtuzumab ozogamicinOncology
GENORBIOgeptanolimabOncology
ABBVIEgiloralimabOncology
ASTELLASgilteritinibOncology
UCBginisortamabOncology
MIRATI THERAPEUTICSglesatinibOncology
AMGENgresonitamabOncology
ASTEXguadecitabineOncology
PHARMACYCLICSibrutinibOncology
GILEADidelalisibOncology
ABBVIEilorasertibOncology
TAKEDAimalumabOncology
ROCHEimgatuzumabOncology
PHOSPLATIN THERAPEUTICSimifoplatinOncology
TAKEDAindusatumabOncology
TAKEDAindusatumab vedotinOncology
LUNDBECKingenol disoxateOncology
BIPARiniparibOncology
BIOCANCELL THERAPEUTICSinodiftagene vixteplasmidOncology
JOHNSON & JOHNSONintetumumabOncology
ACTINIUMiodine (131i) apamistamabOncology
MEREO BIOPHARMipafriceptOncology
GENENTECHipatasertibOncology
SANOFIisatuximabOncology
AGIOSivosidenibOncology
TAKEDAixazomibOncology
SEAGENladiratuzumabOncology
SEAGENladiratuzumab vedotinOncology
MERCK & CO.lapretolimodOncology
IMMUNOGENlaprituximabOncology
IMMUNOGENlaprituximab emtansineOncology
DENDREONlapuleucel-tOncology
VIONlaromustineOncology
LOXO ONCOLOGYlarotrectinibOncology
ONCOTHERAPY SCIENCElatromotideOncology
JANSSENlazertinibOncology
MOLOGENlefitolimodOncology
I-MABlemzoparlimabOncology
ISTARI ONCOLOGYlerapolturevOncology
ISTARI ONCOLOGYlerapolturevOncology
ADAPTIMMUNEletetresgene autoleucelOncology
YM BIOSCIENCESlexibulinOncology
IOVANCE BIOTHERAPEUTICSlifileucelOncology
BEIGENElifirafenibOncology
ABBVIElinifanibOncology
OSI PHARMACEUTICALSlinsitinibOncology
REGENERONlinvoseltamabOncology
CONSTELLATIONlirametostatOncology
ASCENTAGE PHARMAlisaftoclaxOncology
BASILEA PHARMACEUTICAlisavanbulinOncology
JW THERAPEUTICSlisocabtagene maraleucelOncology
ABBVIElivmoniplimabOncology
SIRNAOMICSlixadesiranOncology
TARVEDAlocnartecanOncology
ADC THERAPEUTICSloncastuximabOncology
ADC THERAPEUTICSloncastuximab tesirineOncology
MACROGENICSlorigerlimabOncology
MACROGENICSlorigerlimabOncology
JANSSENlorpucitinibOncology
APEIRONlorukafusp alfaOncology
IMMUNOGENlorvotuzumab mertansineOncology
NOVARTISlucatumumabOncology
GILEADmagrolimabOncology
Inoviomavilimogene ralaplasmidOncology
X4mavorixaforOncology
ONCOPEPTIDESmelphalan flufenamideOncology
SYROSmevociclibOncology
DAIICHI-SANKYOmilademetanOncology
ADC THERAPEUTICSmipasetamabOncology
ADC THERAPEUTICSmipasetamab uzoptirineOncology
TAKARA BIOmipetresgene autoleucelOncology
DEKK-TREKmipicoledineOncology
INSPYR TherapeuticsmipsagarginOncology
ARQULEmiransertibOncology
IMMUNOGENmirvetuximab soravtansineOncology
ABBVIEmirzotamabOncology
ABBVIEmirzotamab clezutoclaxOncology
JANSSENmitazalimabOncology
TAKEDAmivavotinibOncology
TAKEDAmobocertinibOncology
MIRATI THERAPEUTICSmocetinostatOncology
MIRATI THERAPEUTICSmocetinostat dihydrobromideOncology
GSKmolibresibOncology
EnzyChemmosedipimodOncology
GENENTECHmosunetuzumabOncology
CRISPRmotacabtagene lurevgedleucelOncology
BIOLINE RXmotixafortideOncology
MEDIMMUNEmoxetumomab pasudotoxOncology
AMGENmurizatoclaxOncology
GAMAMABSmurlentamabOncology
J-PHARMAnanvuranlatOncology
IMMUNOGENnaratuximab emtansineOncology
MEREO BIOPHARMnavicixizumabOncology
ABBVIEnavitoclaxOncology
KARTOSnavtemadlinOncology
ARQULEnemtabrutinibOncology
ALKERMESnemvaleukin alfaOncology
TARVEDAnendratereotide uzatansineOncology
TARVEDAnendratereotideOncology
AUTOLUSobecabtagene autoleucelOncology
BEIGENEociperlimabOncology
CHECKPOINT THERAPEUTICSolafertinibOncology
ADAPTIMMUNEolitresgene autoleucelOncology
HANMI PHARMACEUTICALSolmutinibOncology
ASCENTAGE PHARMAolverembatinibOncology
TEVA PHARMACEUTICALS INDUSTRIESomacetaxine mepesuccinateOncology
GSKomipalisibOncology
JANSSENonametostatOncology
BRISTOL MYERS SQUIBBonatasertibOncology
BRISTOL MYERS SQUIBBonatasertibOncology
JanssenonvatilimabOncology
TIBURIOonzigolideOncology
JANSSENopolimogene capmilisbacOncology
AMGENoprozomibOncology
TAKEDAorteronelOncology
BRISTOL MYERS SQUIBBorvacabtagene autoleucelOncology
AMGENpacanalotamabOncology
GERONpaclitaxel trevatideOncology
CYTOMX THERAPEUTICSpacmilimabOncology
BEIGENEpamiparibOncology
DAIICHI-SANKYOpatritumabOncology
AMGENpavurutamabOncology
JAZZ PHARMACEUTICALSpegcrisantaspaseOncology
AVELAS BIOSCIENCESpegloprastideOncology
HALOZYME THERAPEUTICSpegvorhyaluronidase alfaOncology
CONSTELLATIONpelabresibOncology
ASCENTAGE PHARMApelcitoclaxOncology
MERCK & CO.pembrolizumabOncology
IncytepemigatinibOncology
JANSSENpemlimogene merolisbacOncology
GSKpemrametostatOncology
SILLAJENpexastimogene devacirepvecOncology
DAIICHI-SANKYOpexidartinibOncology
PDS BIOTECHNOLOGYpexipepimut-sOncology
SANOFIpilaralisibOncology
JOUNCEpimivalimabOncology
GENENTECHpinatuzumab vedotinOncology
EPIZYMEpinometostatOncology
SIRNAOMICSpixofisiranOncology
GENENTECHpolatuzumab vedotinOncology
BRISTOL MYERS SQUIBBpomalidomideOncology
ARIADponatinibOncology
ARIADponatinib hydrochlorideOncology
PFIZERponsegromabOncology
HANMI PHARMACEUTICALSposeltinibOncology
ONCOTHERAPY SCIENCEpradimotideOncology
BLUEPRINT MEDICINESpralsetinibOncology
CYTOMX THERAPEUTICSpraluzatamabOncology
CYTOMX THERAPEUTICSpraluzatamab ravtansineOncology
BIO-PATH HOLDINGSprexigebersenOncology
ARCUSquemliclustatOncology
JOHNSON & JOHNSONquisinostatOncology
BAYERradretumabOncology
BAYERrefametinibOncology
JW PHARMACEUTICALrelmacabtagene autoleucelOncology
4SCresminostatOncology
ABBVIErevdofilimabOncology
BETA PHARMArezivertinibOncology
ACETYLONricolinostatOncology
BELLICUM PHARMACEUTICALSrimiducidOncology
LSK BIOPHARMArivoceranibOncology
ABBVIErizankizumabOncology
CLOVIS ONCOLOGYrociletinibOncology
ABBVIErolinsatamabOncology
ABBVIErolinsatamab talirineOncology
BAYERroniciclibOncology
SYNTA PHARMACEUTICALSrosabulinOncology
MEREO BIOPHARMrosmantuzumabOncology
TELIX PHARMACEUTICALSrosopatamabOncology
TELIX PHARMACEUTICALSrosopatamab tetraxetanOncology
ABBVIErovalpituzumabOncology
ABBVIErovalpituzumab tesirineOncology
GALERA THERAPEUTICSrucosopasem manganeseOncology
GENENTECHrunimotamabOncology
LYTIX BIOPHARMAruxotemitideOncology
ABBVIEsamrotamabOncology
ABBVIEsamrotamab vedotinOncology
TAKEDAsapanisertibOncology
IPSEN BIOPHARM LTDsatoreotide tetraxetanOncology
OCTREOPHARMsatoreotide trizoxetanOncology
ASTRAZENECAsavolitinibOncology
SalariusseclidemstatOncology
KARYOPHARMselinexorOncology
LOXO ONCOLOGYselitrectinibOncology
LOXO ONCOLOGYselpercatinibOncology
JANSSENseltorexantOncology
ASTRAZENECAselumetinibOncology
ASTRAZENECAselumetinib sulfateOncology
TAKEDAserabelisibOncology
ABBVIEserclutamabOncology
ABBVIEserclutamab talirineOncology
JOHNSON & JOHNSONserdemetanOncology
SANOFIseribantumabOncology
INNOCRIN PHARMACEUTICALSseviteronelOncology
TAKEDAsiltocabnagene loxiveleucelOncology
JOHNSON & JOHNSONsiltuximabOncology
GILEADsimtuzumabOncology
TAKEDAsimurosertibOncology
DENDREONsipuleucel-tOncology
MIRATI THERAPEUTICSsitravatinibOncology
SEAGENsonolisibOncology
BAYERsorafenibOncology
AMGENsotorasibOncology
AMGENsovilnesibOncology
THERATECHNOLOGIESsudocetaxel zendusortideOncology
AILERON THERAPEUTICSsulanemadlinOncology
LEAP THERAPEUTICSsurexatamabOncology
BEIGENEsurzebiclimabOncology
ONCOTHERAPYSCIENCEtabituximabOncology
ONCOTHERAPYSCIENCEtabituximab barzuxetanOncology
MORPHOSYStafasitamabOncology
JANSSENtalacotuzumabOncology
PFIZERtalazoparibOncology
ANHEART THERAPEUTICStaletrectinibOncology
ANHEART THERAPEUTICStaletrectinib adipateOncology
JOHNSON & JOHNSONtalmapimodOncology
JANSSENtalquetamabOncology
ABBVIEtamrintamabOncology
ABBVIEtamrintamab pamozirineabOncology
BRISTOL MYERS SQUIBBtanespimycinOncology
AMGENtapotoclaxOncology
MEREO BIOPHARMtarextumabOncology
AMGENtarlatamabOncology
THRESHOLD PHARMACEUTICALStarloxotinib bromideOncology
DNATRIX, Inc.tasadenoturevOncology
GENENTECHtaselisibOncology
OncoSectavokinogene telseplasmidOncology
EPIZYMEtazemetostatOncology
TAKARA BIOtebrocabtagene autoleucelOncology
JANSSENteclistamabOncology
BetaCattegavivintOncology
CALITHERAtelaglenastatOncology
GLENMARK PHARMACEUTICALStelazorlimabOncology
ABBVIEtelisotuzumabOncology
ABBVIEtelisotuzumab vedotinOncology
ASTRAZENECAtelratolimodOncology
ERIMOS PHARMACEUTICALSterameprocolOncology
AURINIAterameprocolOncology
AFFIBODYtezatabep matraxetanOncology
GILEADtilpisertibOncology
IDERA PHARMACEUTICALStilsotolimodOncology
BERGEN BIOtilvestamabOncology
GLYCOTOPEtimigutuzumabOncology
PFIZERtinlorafenibOncology
MUNDIPHARMAtinostamustineOncology
GILEADtirabrutinibOncology
GENENTECHtiragolumabOncology
ATHENEXtirbanibulinOncology
GENEXINEtirvalimogene teraplasmidOncology
NOVARTIStisagenlecleucelOncology
BEIGENEtislelizumabOncology
DAIICHI-SANKYOtivantinibOncology
EffectortomivosertibOncology
GLYCOTOPEtomuzotuximabOncology
BLAZE BIOSCIENCEtozuleristideOncology
AMGENtrebananibOncology
SHIONOGI PHARMAtrempamotideOncology
SEAGENtucatinibOncology
BLACK DIAMONDtuxobertinibOncology
REGENERON PHARMACEUTICALSubamatamabOncology
I-MABuliledlimabOncology
BIOMED VALLEYulixertinibOncology
GSKuprosertibOncology
SURFACE ONCOLOGYurabrelimabOncology
BRISTOL MYERS SQUIBBvadacabtagene leraleucelOncology
BRISTOL MYERS SQUIBBvadacabtagene leraleucelOncology
SEAGENvadastuximabOncology
SEAGENvadastuximab talirineOncology
CHONG KUN DANGvalecobulinOncology
MEREO BIOPHARMvantictumabOncology
SUNESIS PHARMACEUTICALSvecabrutinibOncology
INTREXONveledimexOncology
ABBVIEveliparibOncology
ABBVIEvenetoclaxOncology
AMGENvepsitamabOncology
MYRIADverubulinOncology
GILEADvesatolimodOncology
ARQULEvevorisertibOncology
CELLIDvibapapogene autoleucelOncology
DECIPHERA PHARMACEUTICALSvimseltinibOncology
AMPHIVENAvixtimotamabOncology
SPARCvodobatinibOncology
JouncevopratelimabOncology
AGIOSvorasidenibOncology
AGIOSvorasidenib citrateOncology
TYROGENEXvorolanibOncology
SEAGENvorsetuzumab mafodotinOncology
MEI PHARMAvoruciclibOncology
SUNESIS PHARMACEUTICALSvosaroxinOncology
RADIUS HEALTHvosilasarmOncology
JANSSENvoxalatamabOncology
SANOFIvoxtalisibOncology
IPSEN BIOPHARM LTDzalsenertant tetraxetanOncology
MILTENYIzamtocabtagene autoleucelOncology
MEI PHARMAzandelisibOncology
ZYMEWORKSzanidatamabOncology
ZYMEWORKSzanidatamab zovodotinOncology
BEIGENEzanubrutinibOncology
GSKzastumotideOncology
MARKER THERAPEUTICSzedenoleucelOncology
MARKER THERAPEUTICSzedenoleucelOncology
AMGENzeluvalimabOncology
MERUSzenocutuzumabOncology
BOSTON PHARMACEUTICALSzeteletinibOncology
BOSTON PHARMACEUTICALSzeteletinib adipateOncology
KURA ONCOLOGYziftomenibOncology
VELOSBIOzilovertamabOncology
VELOSBIOzilovertamab vedotinOncology
ARCUSzimberelimabOncology
ASTELLASzolbetuximabOncology
EFFECTORzotatifinOncology